Microcarrier Market Report
Microcarrier Market by Product Type (Equipment and Consumables), Application (Pharmaceutical Manufacturing, Cell Therapy, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027
Microcarriers are small beads less than 500 μm (micro meter) in size with surfaces used to support cell attachment. These beads are kept in suspension medium at very low of stimulating speeds in order to avoid physical cell damage either due to frictional forces in the liquid or due to collisions between beeds. They are utilized in the large-scale generation of protein generating cells.
Microcarrier Market Analysis:
The microcarrier market is expected to witness a notable growth because of rising number of cancer patients globally because microcarriers are used in treatment of cancer cells. These factors are expected to propel the growth of the market.
The growing number of cancer patients is one of the main driving factors of the microcarrier market
The growing number of cancer patients globally is predicted to drive the microcarrier market in the forecast period. As per, International Agency for Research on Cancer, there are around 2 million new cases of cancer in 2020 globally. In addition to this, the increasing demand in the stem cell method with the use of microcarrier the largescale production of cells is possible. These factors are contributing the growth of the market in the forecast period.
High cost of cell biology research is estimated to restrain the growth of global microcarrier market
Cell biology requires extensive research and development of stem cells and other genetic therapies. The equipment required for research and the reagents needed are very costly. These factors can hamper the demand of global microcarrier market.
The growing demand for monoclonal antibodies is likely to provide lucrative opportunities for microcarrier market.
The increasing demand for monoclonal antibodies is anticipated to grow the demand for the microcarrier market. Monoclonal antibodies are utilized for purposes such as oncology, autoimmune, and treatment of inflammatory disorders. Microcarriers are utilized for production of monoclonal antibodies. Factors like these will open new scope of opportunities for microcarrier market.
Microcarrier Market, by Product Type:
Equipment sub segment is expected to be most lucrative segment in the forecast period
On the basis of product type, the microcarrier market is sub-segmented into equipment and consumables. Equipment sub-segment is anticipated to grow during the forecast timeframe. Equipment are utilized for the large-scale production of proteins along with bioreactors for the better growth of adherent cells on microcarrier.
Microcarrier Market, by Application:
Pharmaceutical sub-segment is anticipated to register significant growth till 2027
On the basis of application, this market is sub-categorized into pharmaceutical manufacturing, cell therapy, and others. Pharmaceutical sub-segment is anticipated to grow considerably during the forecast period due to continuous growing need for vaccines for different diseases companies such as Pfizer Inc., Merck & Co., Inc. and others do research on cell research.
Microcarrier Market, by Region:
North American region is expected to dominate this market in the forecast period
North American is expected to dominate this market due to the increase in number of cancer patients in the region and presence of organizations such as ASGCT (American Society of Gene & Cell Therapy) for promoting and imparting emphasis on cell research. In addition to this, the presence of major pharma companies such as Johnson & Johnson, Novartis, and Pfizer Inc. enabled having a strong pharmaceutical infrastructure in the region.
Asia-Pacific region is expected to have immense opportunities for the market investors
Asia-Pacific region has a rapidly growing market and is anticipated to experience a remarkable growth in the forecast timeframe. The growing emphasis on promoting cell research by organizations such as Asian-Pacific Organization for Cell Biology (APOCB) and presence of major pharmaceutical manufacturing hub such as India. These factors are estimated to boost the growth of the market in the region market.
To explore more about microcarrier market, get in touch with our analysts here.
Key Participants in the Global Microcarrier Market:
Merger & acquisition and advanced product development are the frequent strategies followed by the market players
Source: Research Dive Analysis
Some of the significant microcarrier market players include Danaher Corporation, Eppendorf AG, Becton Dickinson and Company, Lonza Group, Thermo Fisher Scientific, HiMedia Laboratories, Merck & Co., Inc., GE Healthcare, Sartorius, Corning Incorporated.
Market players prefer inorganic growth strategies to expand into local markets.
Microcarrier market players are emphasizing more on merger & acquisition and advanced product development. These are the frequent strategies followed by established organizations. To emphasize more on the competitor analysis of market players, the Porter’s five force model is explained in the report.
Historical Market Estimations
Base Year for Market Estimation
Forecast timeline for Market Projection
North America, Europe, Asia-Pacific, LAMEA
Segmentation by Product Type
Segmentation by Application
Key Countries Covered
U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia
Key Companies Profiled
Q1. Which are the leading companies in the microcarrier market?
A. Merck & Co., Inc., and GE Healthcare are some of the key players in the global Microcarrier Market.
Q2. Which region possesses greater investment opportunities in the coming future?
A. The Asia-Pacific region possesses great investment opportunities for the investors to witness the most promising growth in the future.
Q3. What are the strategies opted by the leading players in this market?
A. Technological advancements, product development, along with joint ventures are the key strategies opted by the operating companies in this market.
Q4. Which companies are investing more in R&D practices?
A. GE Healthcare, and Danaher Corporation companies are investing more in R&D activities for developing new products and technologies.